Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Vera Therapeutics, Inc. (VERA) had Debt to Capital Ratio of 0.11 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-299.62M |
|
-- |
|
-- |
|
$315.47M |
|
$-315.47M |
|
$15.86M |
|
$-299.61M |
|
$-299.61M |
|
$-299.61M |
|
$-299.61M |
|
$-299.61M |
|
$-299.61M |
|
$-315.47M |
|
$-320.13M |
|
64.23M |
|
64.23M |
|
$-4.66 |
|
$-4.66 |
|
| Balance Sheet Financials | |
$728.88M |
|
$1.37M |
|
$5.85M |
|
$734.73M |
|
$53.45M |
|
$74.84M |
|
$76.76M |
|
$130.21M |
|
$604.52M |
|
$604.52M |
|
$604.52M |
|
71.27M |
|
| Cash Flow Statement Financials | |
$-241.10M |
|
$194.29M |
|
$308.90M |
|
$92.65M |
|
$354.73M |
|
$262.08M |
|
$37.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.64 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.11 |
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-241.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.56% |
|
-49.56% |
|
-40.78% |
|
-44.10% |
|
$8.48 |
|
$-3.76 |
|
$-3.75 |
|